MORGAN STANLEY - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$664,184
+144.9%
259,447
+139.2%
0.00%
Q2 2023$271,188
-1.7%
108,475
-17.4%
0.00%
Q1 2023$275,770
+321.9%
131,319
+211.4%
0.00%
Q4 2022$65,371
-66.8%
42,175
-34.7%
0.00%
Q3 2022$197,000
+9.4%
64,570
+13.1%
0.00%
Q2 2022$180,000
+63.6%
57,089
+46.1%
0.00%
Q1 2022$110,000
-10.6%
39,076
+42.6%
0.00%
Q4 2021$123,000
-47.7%
27,404
-2.9%
0.00%
Q3 2021$235,00028,2360.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$2,835,00016.79%
DC Investments Management, LLC 35,563$160,0000.23%
Deer Management Co. LLC 1,245,505$5,605,0000.14%
Alphabet Inc. 1,077,080$4,847,0000.12%
RA Capital Management 1,255,317$5,649,0000.10%
HHLR ADVISORS, LTD. 1,282,976$5,773,0000.09%
Nan Fung Group Holdings Ltd 48,600$219,0000.06%
Baker Brothers Advisors 1,425,000$6,413,0000.03%
Tekla Capital Management LLC 200,000$900,0000.03%
Marquette Asset Management, LLC 21,618$97,0000.02%
View complete list of TSCAN THERAPEUTICS INC shareholders